Midway Immunology and Research Center at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Midway Immunology and Research Center brings 4 presentations to IDWeek 2026 in Washington. Its program centres on newer HIV treatment regimens and how they perform in people with other health conditions. It reports safety and metabolic results for the BIC/LEN single-tablet regimen in people with dyslipidemia, hypertension or diabetes, plus subgroup results after a switch to doravirine/islatravir.
| Organization | IDWeek 2026 Attendance |
|---|---|
MI Midway Immunology and Research Center Fort Pierce, FL | |
Industry Wed Oct 21 7:00pm–9:00pm Voice of the ART (ists): Dinner Symposium- food is provided by IDWeek HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship Poster Thu Oct 22 12:15pm–1:30pm Metabolic and Safety Outcomes With BIC/LEN Single-Tablet Regimen in People With HIV And Comorbidities in ARTISTRY-2 Poster Thu Oct 22 12:15pm–1:30pm Safety Analysis of BIC/LEN Single-Tablet Regimen in People With HIV Who Have Comorbidities of Dyslipidemia, Hypertension, and Diabetes Mellitus From Phase 3 of ARTISTRY-1 Talk Fri Oct 23 1:57pm–2:09pm Efficacy and Safety by Demographic Subgroup After Switch to Doravirine/Islatravir (100 mg/0.25 mg) Once Daily: Week 96 Results From Two Randomized, Active-Controlled Phase 3 Studies in Adults Living With HIV-1 HIV, sexually transmitted infections and viral hepatitisAntimicrobials, resistance and stewardship |
Instantly find 20 buyers from Midway Immunology and Research Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction